These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21873659)

  • 41. Heritability of the severity of diabetic retinopathy: the FIND-Eye study.
    Arar NH; Freedman BI; Adler SG; Iyengar SK; Chew EY; Davis MD; Satko SG; Bowden DW; Duggirala R; Elston RC; Guo X; Hanson RL; Igo RP; Ipp E; Kimmel PL; Knowler WC; Molineros J; Nelson RG; Pahl MV; Quade SR; Rasooly RS; Rotter JI; Saad MF; Scavini M; Schelling JR; Sedor JR; Shah VO; Zager PG; Abboud HE;
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3839-45. PubMed ID: 18765632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. C-reactive protein genetic variant is associated with diabetic retinopathy in Chinese patients with type 2 diabetes.
    Peng D; Wang J; Zhang R; Tang S; Jiang F; Chen M; Yan J; Sun X; Wang T; Wang S; Bao Y; Hu C; Jia W
    BMC Endocr Disord; 2015 Mar; 15():8. PubMed ID: 25887518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chromosome 15q21-22-related polymorphisms and haplotypes are associated with susceptibility to type-2 diabetic nonproliferative retinopathy.
    Hsieh YY; Huang YC; Chang CC; Wang YK; Lin WH; Tsai FJ
    Genet Test Mol Biomarkers; 2012 May; 16(5):442-8. PubMed ID: 22409602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy.
    Fujisawa T; Ikegami H; Kawaguchi Y; Hamada Y; Ueda H; Shintani M; Fukuda M; Ogihara T
    Diabetologia; 1998 Jan; 41(1):47-53. PubMed ID: 9498629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Association of Transcription Factor 7 like 2 Gene Polymorphism with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.
    Morgan MF; Salam RF; Rady NH; Alnaggar ARLR; Ammar SH; Ghanem NS
    Curr Diabetes Rev; 2020; 16(4):370-375. PubMed ID: 31288725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. VEGF -634G>C polymorphism and diabetic retinopathy risk: a meta-analysis.
    Qiu M; Xiong W; Liao H; Li F
    Gene; 2013 Apr; 518(2):310-5. PubMed ID: 23353010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-10 -1082A > G (rs1800896) polymorphism is associated with diabetic retinopathy in type 2 diabetes.
    da Silva Pereira BL; Polina ER; Crispim D; Sbruzzi RC; Canani LH; Dos Santos KG
    Diabetes Res Clin Pract; 2018 Apr; 138():187-192. PubMed ID: 29382585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African Americans.
    Guan M; Ma J; Keaton JM; Dimitrov L; Mudgal P; Stromberg M; Bonomo JA; Hicks PJ; Freedman BI; Bowden DW; Ng MC
    Hum Genet; 2016 Nov; 135(11):1251-1262. PubMed ID: 27461219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genome-wide association study identifies new susceptibility loci for diabetic nephropathy in Korean patients with type 2 diabetes mellitus.
    Jeong KH; Kim JS; Woo JT; Rhee SY; Lee YH; Kim YG; Moon JY; Kim SK; Kang SW; Lee SH; Kim YH;
    Clin Genet; 2019 Jul; 96(1):35-42. PubMed ID: 30883692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control.
    Pollack S; Igo RP; Jensen RA; Christiansen M; Li X; Cheng CY; Ng MCY; Smith AV; Rossin EJ; Segrè AV; Davoudi S; Tan GS; Chen YI; Kuo JZ; Dimitrov LM; Stanwyck LK; Meng W; Hosseini SM; Imamura M; Nousome D; Kim J; Hai Y; Jia Y; Ahn J; Leong A; Shah K; Park KH; Guo X; Ipp E; Taylor KD; Adler SG; Sedor JR; Freedman BI; ; Lee IT; Sheu WH; Kubo M; Takahashi A; Hadjadj S; Marre M; Tregouet DA; Mckean-Cowdin R; Varma R; McCarthy MI; Groop L; Ahlqvist E; Lyssenko V; Agardh E; Morris A; Doney ASF; Colhoun HM; Toppila I; Sandholm N; Groop PH; Maeda S; Hanis CL; Penman A; Chen CJ; Hancock H; Mitchell P; Craig JE; Chew EY; Paterson AD; Grassi MA; Palmer C; Bowden DW; Yaspan BL; Siscovick D; Cotch MF; Wang JJ; Burdon KP; Wong TY; Klein BEK; Klein R; Rotter JI; Iyengar SK; Price AL; Sobrin L
    Diabetes; 2019 Feb; 68(2):441-456. PubMed ID: 30487263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of the receptor for advanced glycation end products gene polymorphisms with diabetic retinopathy in type 2 diabetes: a meta-analysis.
    Yuan D; Yuan D; Liu Q
    Ophthalmologica; 2012; 227(4):223-32. PubMed ID: 22354095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes.
    Buraczynska M; Wacinski P; Zukowski P; Dragan M; Ksiazek A
    J Diabetes Complications; 2014; 28(1):35-9. PubMed ID: 24075694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymorphisms in the CTSH gene may influence the progression of diabetic retinopathy: a candidate-gene study in the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987).
    Thorsen SU; Sandahl K; Nielsen LB; Broe R; Rasmussen ML; Peto T; Grauslund J; Andersen ML; Mortensen HB; Pociot F; Olsen BS; Brorsson C
    Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):1959-65. PubMed ID: 26245339
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of genetic variants in the receptor for advanced glycation end products gene with diabetic retinopathy: A meta-analysis.
    Yu W; Yang J; Sui W; Qu B; Huang P; Chen Y
    Medicine (Baltimore); 2016 Sep; 95(39):e4463. PubMed ID: 27684793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy.
    Ciccacci C; Di Fusco D; Cacciotti L; Morganti R; D'Amato C; Novelli G; Sangiuolo F; Spallone V; Borgiani P
    Acta Diabetol; 2013 Oct; 50(5):789-99. PubMed ID: 22843023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of DNA repair genes XRCC3 and XRCC1 in predisposition to type 2 diabetes mellitus and diabetic nephropathy.
    Yesil-Devecioglu T; Dayan A; Demirtunc R; Sardas S
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Feb; 66(2):90-98. PubMed ID: 30472145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The predictive value of diabetic retinopathy on subsequent diabetic nephropathy in patients with type 2 diabetes: a systematic review and meta-analysis of prospective studies.
    Li Y; Su X; Ye Q; Guo X; Xu B; Guan T; Chen A
    Ren Fail; 2021 Dec; 43(1):231-240. PubMed ID: 33478336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genome-Wide Associations and Confirmatory Meta-Analyses in Diabetic Retinopathy.
    Yu X; Rong S
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymorphisms in
    Dieter C; Lemos NE; de Faria Corrêa NR; Assmann TS; Pellenz FM; Canani LH; de Almeida Brondani L; Bauer AC; Crispim D
    Arch Endocrinol Metab; 2023 May; 67(5):e000624. PubMed ID: 37249455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of TNF-α-308G/A Polymorphism on the Risk of Diabetic Nephropathy and Diabetic Retinopathy: An Updated Meta-Analysis.
    Liu M; Shang M; Wang Y; Li Q; Liu X; Yang L; Zhang Q; Zhang K; Liu S; Nie F; Zeng F; Wen Y; Liu W
    Horm Metab Res; 2020 Oct; 52(10):724-731. PubMed ID: 32369834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.